FDA warns Indian drugmaker over quality lapses, clinical researcher for enrollment issues
Regulatory NewsFerdous Al-Faruque
APIsAudit/inspectionClinical TrialsGCPGMPPharmaceuticalsUnited StatesWarning lettersRegulatory NewsFerdous Al-FaruqueAPIsAudit/inspectionClinical TrialsGCPGMPPharmaceuticalsUnited StatesWarning letters